Danaher Co. (NYSE:DHR) Shares Purchased by Phraction Management LLC

Phraction Management LLC lifted its holdings in Danaher Co. (NYSE:DHR) by 1.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 37,062 shares of the conglomerate’s stock after purchasing an additional 607 shares during the period. Danaher makes up 3.0% of Phraction Management LLC’s holdings, making the stock its 14th biggest holding. Phraction Management LLC’s holdings in Danaher were worth $8,508,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in DHR. Heck Capital Advisors LLC acquired a new position in Danaher during the 4th quarter worth approximately $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher during the 4th quarter worth approximately $31,000. Golden State Wealth Management LLC acquired a new position in Danaher during the 4th quarter worth approximately $31,000. Teachers Insurance & Annuity Association of America acquired a new position in Danaher during the 3rd quarter worth approximately $39,000. Finally, MidAtlantic Capital Management Inc. acquired a new position in Danaher during the 3rd quarter worth approximately $40,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on the stock. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Scotiabank began coverage on shares of Danaher in a research report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price objective for the company. Bank of America upgraded shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective for the company in a research report on Friday, December 13th. TD Cowen upped their price target on shares of Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 price target (down previously from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $278.00.

Danaher Price Performance

Shares of NYSE DHR opened at $202.22 on Thursday. The stock has a market cap of $146.06 billion, a price-to-earnings ratio of 38.30, a PEG ratio of 2.68 and a beta of 0.83. Danaher Co. has a 52 week low of $196.80 and a 52 week high of $281.70. The company’s 50-day moving average price is $231.17 and its 200 day moving average price is $250.62. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the business posted $2.09 EPS. As a group, research analysts forecast that Danaher Co. will post 7.67 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a $0.27 dividend. The ex-dividend date was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.53%. Danaher’s dividend payout ratio (DPR) is 20.45%.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 11.10% of the stock is owned by insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.